Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.
about
The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesisPlasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.Therapeutic potential of an orally effective small molecule inhibitor of plasminogen activator inhibitor for asthma.Role of urokinase receptor in tumor progression and development.Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-βOverexpression of SerpinE2/protease nexin-1 Contribute to Pathological Cardiac Fibrosis via increasing Collagen Deposition.Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular DiseaseGAP-independent functions of DLC1 in metastasis.Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures.Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1PAI-1: An Integrator of Cell Signaling and Migration.Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils.A slow-cycling subpopulation of melanoma cells with highly invasive properties.Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes.Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.Spontaneous metastasis in congenic mice with transgenic breast cancer is unaffected by plasminogen gene ablation.Plasminogen activation is required for the development of radiation-induced dermatitis
P2860
Q34258429-9CC3AC14-418D-4B33-90D8-B05A8A4AA4E8Q34735474-CC61EE87-6394-4A41-9EA2-0C8457D84640Q35178613-879F125A-3C33-4884-9DA2-106DE9CD737CQ35764595-BAC8CB03-0A6C-4BC9-BE59-A35DC28C7B0DQ36583859-AFC29C8A-B051-4D56-9528-B92946341733Q36997616-6B436996-A56F-4ADC-80DF-E94A84C84BB0Q37270591-6180D35B-4779-4524-B7F8-6F7BE1DBF7A4Q37431141-58B4D4B3-D90F-4EC2-B815-29FEB9486181Q37801943-2458D224-7477-4CAB-85C6-DDF266DC2BA9Q38128321-DFDD2C3E-E1F5-40A1-BED1-63165ADFA3AEQ38171331-62E4900C-EA7A-423E-A28F-A9C994302CACQ38804110-406CE032-91BD-49F6-B436-A7368464A7D1Q39264728-E6912B0F-A86F-4A8E-B609-19AF2E4731B1Q39422383-DA304A61-3342-4CA1-B1F7-1C68632D53A9Q39663692-DA9EDC04-AFFB-42A6-BAEE-48A97B6EC65BQ41896599-89799185-8DC4-452C-8959-E3DF5355916FQ41973656-9CC93498-8EC4-4AF0-9FA1-FEA9E0C715E7Q41996634-F8868783-2487-4161-BFCB-483757088504Q42649852-B36F0AD9-4708-45EB-A329-8239B797514FQ51361802-B4F006CC-DB54-40A6-AFE3-572293B759D3Q53732349-33787BB4-EDEB-4DAB-892B-6C29A391FCEFQ57461777-BA8E15A9-D656-44CD-BE56-DA86910D19D5
P2860
Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Plasminogen activator inhibito ...... gh a uPAR-dependent mechanism.
@en
Plasminogen activator inhibito ...... gh a uPAR-dependent mechanism.
@nl
type
label
Plasminogen activator inhibito ...... gh a uPAR-dependent mechanism.
@en
Plasminogen activator inhibito ...... gh a uPAR-dependent mechanism.
@nl
prefLabel
Plasminogen activator inhibito ...... gh a uPAR-dependent mechanism.
@en
Plasminogen activator inhibito ...... gh a uPAR-dependent mechanism.
@nl
P2860
P356
P1476
Plasminogen activator inhibito ...... gh a uPAR-dependent mechanism.
@en
P2093
David J Loskutoff
Ralf-Peter Czekay
P2860
P304
P356
10.1002/JCP.21806
P577
2009-09-01T00:00:00Z